Skip to main content
Figure 1 | BMC Infectious Diseases

Figure 1

From: The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C

Figure 1

Overall, 78 anti-HCV positive patients were screened for HCV-RNA. IN 65 patients (83.3%) HCV-RNA was detected. In 13 patients (16.7%) no HCV-RNA was found upon repeated testing, suggesting viral clearance in these patients. There is a trend towards a higher rate of viral clearance in patients without NOSA compared to patients with NOSA (p = 0.07, Fisher's exact test). NOSA, non-organ-specific autoantibodies.

Back to article page